AMERICAN PHARMACISTS ASSOCIATION for AMERICAN PHARMACISTS ASSOCIATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislative and agency issues regarding drug shortages, the reauthorization of the Prescription Drug User Fee Act (PDUFA), drug counterfeiting, supply chain integrity, drug diversion and controlled substance monitoring. Also, the Health Care and Education Reconciliation Act of 2010 (P.L. 111-145) and the Patient Protection and Affordability Act (P.L. 111-148) including sections concerning Medicare Part D changes; medication therapy management (MTM); accountable care organizations (ACOs); durable medical equipment (DME); Center for Medicare and Medicaid Innovation within CMS; transitions of care; essential health benefits (EHB); and providing adequate pharmacy reimbursement (AMP).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | — |
| BRIAN GALLAGHER | — |
| ABBIE LAUGTUG | — |
| MICHAEL SPIRA | — |
Medicare/Medicaid MMM
S. 274 Medication Therapy Management Empowerment Act of 2011. H.R. 891 Medication Therapy Management Benefits Act of 2011. Agency issues related to standardized medication action plans; accountable care organizations (ACOs); pharmacists' participation in CMS Innovation Center initiatives; coverage for outpatient drugs; transparency and reporting of physician investment interests (Sunshine Act); potential new paradigm for drugs; essential health benefits (EHB); and standardized pharmacy notice.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | — |
| BRIAN GALLAGHER | — |
| ABBIE LAUGTUG | — |
| MICHAEL SPIRA | — |
Budget/Appropriations BUD
Legislative and agency issues regarding the Patient Protection and Affordable Care Act (P.L. 111-148) - Appropriations for the medication therapy management grant program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | — |
| BRIAN GALLAGHER | — |
| ABBIE LAUGTUG | — |
| MICHAEL SPIRA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.